U.S. Professional Services Stock News

Why Merck stock is back in focus Merck (MRK) is back on investors radars after the FDA approved KEYTRUDA and its subcutaneous QLEX formulation for platinum-resistant ovarian cancer, alongside fresh oncology data heading to the 2026 ASCO GU symposium. This new indication makes KEYTRUDA the first PD-1 inhibitor cleared for this difficult ovarian cancer population, supported by Phase 3 results. The upcoming genitourinary presentations highlight how central oncology remains to Merck's long-term...

Cipher Mining (CIFR) is reshaping its business beyond crypto mining, anchored by a US$3b, 10-year Fluidstack partnership for AI focused data centers and a US$2b private placement backing its Black Pearl high performance computing facility. See our latest analysis for Cipher Mining. At a share price of US$16.42, Cipher Mining has seen momentum swing around its news flow, with an 11.47% 7 day share price return and a 14.43% 90 day share price return sitting alongside a 1 year total shareholder...

If you are wondering whether Alkermes at around US$33.16 is offering good value right now, this article will walk through what the numbers actually suggest. The share price performance shows a mixed picture, with a 5% decline over the last 7 days, a 4.8% gain over the last 30 days, a 17.3% gain year to date, and a 7.6% decline over the last year alongside gains of 20.1% over 3 years and 72.1% over 5 years. Recent coverage has focused on Alkermes as a long established player in the...

Match Group reported past fourth-quarter 2025 sales of US$878.01 million and net income of US$209.65 million, alongside full-year 2025 sales of US$3.49 billion and a higher annual profit, while also updating its 2026 revenue outlook to be roughly flat year-on-year. Alongside the earnings release, Match Group raised its quarterly dividend, completed a sizeable share repurchase program, and highlighted cost savings that are being redirected into AI-driven product innovation and...

What ABM Industries (ABM) investors may be watching now ABM Industries (ABM) recently closed at $44.51, with shares showing a 2.46% move over the past day, a small decline over the past month, and a gain across the past 3 months. See our latest analysis for ABM Industries. That 2.46% 1 day share price gain comes after a 6.41% 7 day share price pullback. The 90 day share price return of 10.42% suggests momentum has been rebuilding even as the 1 year total shareholder return of 13.92% remains...

In recent days, ServiceNow has accelerated its AI push through new alliances such as Kearney’s BPR.ai offering, multiple AI-focused acquisitions, and the appointment of Danielle Fontaine as Chief Accounting Officer and Corporate Controller following her prior role as Assistant Controller. Together with upbeat analyst research and growing ecosystem activity on its platform, these moves highlight how ServiceNow is being framed as an AI workflow “control tower” rather than a software company at...

If you are looking at Doximity and wondering whether the current share price offers value, this article will walk through what the numbers actually say rather than just the headlines. The stock has recently been under pressure, with returns of a 9.8% decline over 7 days, 39.4% decline over 30 days, 42.2% decline year to date and 67.5% decline over the past year from a last close of US$25.02. Recent coverage has focused on Doximity as a leading digital platform for U.S. physicians and how its...

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...

Costco Wholesale (COST) is back in focus after reporting January net sales of US$21.33b, up 9.3% year over year, with digital and e-commerce channels taking a larger share of revenue. See our latest analysis for Costco Wholesale. The latest US$21.33b January sales update and growing digital mix come on top of strong price momentum, with Costco’s 30 day share price return of 5.69% and year to date share price return of 19.19%, while its 3 year total shareholder return of 109.03% contrasts with...

In early February 2026, TransMedics Group, Inc. received full U.S. FDA approval for its Investigational Device Exemption for the Next-Generation OCS ENHANCE Heart trial, advancing a two-part study designed to support prolonged heart perfusion and compare OCS Heart with traditional static cold storage in brain-dead donor cases. This full IDE approval, following recent green lights for the company’s next-generation lung trial, highlights regulatory momentum behind its organ care platform and...

Assurant (AIZ) is back in focus after reporting Q4 and full year 2025 results, sharing higher revenue and earnings, along with a fresh push into home warranty and continued share repurchases. See our latest analysis for Assurant. Those earnings, the Assurant Home Warranty launch and ongoing buybacks have arrived against a choppy backdrop. A 7 day share price return of 10.62% and a 30 day share price return of 7.06% point to fading near term momentum, while the 1 year total shareholder return...

Why Restaurant Brands International Is On Investors’ Radar Today Restaurant Brands International (QSR) is catching attention after recent share price moves, with the stock down about 3% over the past month and roughly 3% over the past 3 months. That pullback comes as the company reports annual revenue of US$9.4b and net income of US$902 million, giving investors fresh numbers to weigh against the current share price of US$66.14. See our latest analysis for Restaurant Brands...

Recent trading in Bio-Rad Laboratories (BIO) has drawn attention after a series of negative returns over the past month and past 3 months, prompting investors to reassess what the current share price may already reflect. See our latest analysis for Bio-Rad Laboratories. With the share price at US$256.56 after a 12.26% one-day and 18.17% 30-day share price decline, recent weakness sits against a longer backdrop of pressured total shareholder returns, including a 46.91% 3-year and 59.72%...

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...

nVent Electric (NVT) is back in focus after reporting fourth quarter and full year 2025 results that paired sharp year over year growth in sales and earnings with renewed analyst confidence. See our latest analysis for nVent Electric. At a share price of $113.25, nVent Electric has seen an 8.8% 90 day share price return and a very strong 1 year total shareholder return of 67.43%, which points to momentum building around its earnings progress, datacenter exposure and acquisition pipeline, even...

What the latest quarter means for Monolithic Power Systems stock Monolithic Power Systems (MPWR) just posted record quarterly revenue and earnings that came in ahead of analyst expectations, with demand in enterprise data, communications, and automotive driving the story and helping explain the recent share move. See our latest analysis for Monolithic Power Systems. At a share price of US$1,171.47, Monolithic Power Systems has a 30-day share price return of 13.39% and a 90-day share price...

IBM has agreed to acquire Confluent in a definitive deal, bringing the data streaming specialist into its broader enterprise software portfolio. The agreement follows strong quarterly revenue and earnings results from Confluent, which trades under ticker NasdaqGS:CFLT. The transaction marks a major ownership shift for Confluent shareholders at a current share price of $30.56. For investors watching NasdaqGS:CFLT, this deal comes after a mixed share price record, with the stock up 20.5% over...

Invesco (NYSE:IVZ) reported a significant rise in assets under management, supported by strong net long term inflows. Investor demand across the firm’s ETF, active, and private market platforms contributed to the higher preliminary AUM figures. The update highlights broad interest in Invesco’s product set during a period of supportive market conditions. For shareholders, the latest AUM update arrives with Invesco shares trading at $26.52. The stock has returned 49.2% over the past year and...

Rigetti Computing (RGTI) is back in focus after a TD Cowen downgrade, with the firm highlighting more than US$300 million in potential fabrication funding needs, rising competitive pressure, and the company’s absence from DARPA QBI Stage B participation. See our latest analysis for Rigetti Computing. The TD Cowen downgrade comes after a sharp reset in Rigetti’s momentum, with a 37.2% 1 month share price return decline and a 31.8% year to date share price return drop, even though the 3 year...

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...

In February 2026, Housecall Pro announced a new native integration with Yelp, allowing high-intent Yelp “Request a Quote” leads to flow directly into Housecall Pro’s Job Inbox alongside leads from Google, Thumbtack and other platforms, while Yelp also reported 2025 net revenue of US$1.46 billion and net income of US$145.60 million and issued 2026 revenue guidance of US$1.46 billion to US$1.48 billion. Despite record 2025 results and expanded AI initiatives, including the Hatch acquisition...

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...

Wondering if Klarna Group at US$18.11 is a bargain or a value trap? This article walks you through what the current price might really be telling you. The stock has recently seen sharp moves, with a 7 day return of an 11.7% decline and a 30 day return of a 37.6% decline, and it sits 36.6% below its year to date level. Recent headlines around Klarna Group have kept investor attention on the business model and competitive position, which helps frame these price swings. This article uses that...